Targeting alpha-4 integrin with natalizumab for intermediate uveitis associated with multiple sclerosis

Aicee Dawn Calma, Stephanie Young, Jennifer Sandbach, Sean Riminton, Stephen W Reddel, Sudarshini Ramanathan

Open source

DOI: 10.1177/20552173241301034
Published: 2024-10
Container: Multiple Sclerosis Journal - Experimental, Translational and Clinical
Publisher: SAGE Publications
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/20552173241301034,
  title = {Targeting alpha-4 integrin with natalizumab for intermediate uveitis associated with multiple sclerosis},
  author = {Aicee Dawn Calma and Stephanie Young and Jennifer Sandbach and Sean Riminton and Stephen W Reddel and Sudarshini Ramanathan},
  year = {2024},
  journal = {Multiple Sclerosis Journal - Experimental, Translational and Clinical},
  doi = {10.1177/20552173241301034},
  url = {https://doi.org/10.1177/20552173241301034}
}

RIS

TY  - JOUR
TI  - Targeting alpha-4 integrin with natalizumab for intermediate uveitis associated with multiple sclerosis
AU  - Aicee Dawn Calma
AU  - Stephanie Young
AU  - Jennifer Sandbach
AU  - Sean Riminton
AU  - Stephen W Reddel
AU  - Sudarshini Ramanathan
PY  - 2024
JO  - Multiple Sclerosis Journal - Experimental, Translational and Clinical
DO  - 10.1177/20552173241301034
UR  - https://doi.org/10.1177/20552173241301034
ER  -

APA

Calma, A. D., Young, S., Sandbach, J., Riminton, S., Reddel, S. W., & Ramanathan, S. (2024). Targeting alpha-4 integrin with natalizumab for intermediate uveitis associated with multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical. https://doi.org/10.1177/20552173241301034

Source records

crossref · retrieved 2026-09-25T12:02:23.902Z